Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?

Ren, Lei; Mota Reyes, Carmen; Friess, Helmut; Demir, Ihsan Ekin

Ren, Lei; Mota Reyes, Carmen; Friess, Helmut; Demir, Ihsan Ekin.

Afiliación

Ren L; Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, D-81675, Munich, Germany.
Mota Reyes C; Department of General Surgery (Gastrointestinal Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Friess H; Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, D-81675, Munich, Germany.
Demir IE; Department of Surgery, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Ismaninger Str. 22, D-81675, Munich, Germany.

Langenbecks Arch Surg ; 405(7): 879-887, 2020 Nov.

Article en En | MEDLINE | ID: mdl-32776259

Asunto(s)

Terapia Neoadyuvante; Neoplasias Pancreáticas; Protocolos de Quimioterapia Combinada Antineoplásica; Humanos; Estadificación de Neoplasias; Pancreatectomía; Neoplasias Pancreáticas/patología

Palabras clave

Arterial resection; Immunotherapy; Neoadjuvant therapy; Pancreatic cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Terapia Neoadyuvante Límite: Humans Idioma: En Revista: Langenbecks Arch Surg Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google